Ariane Söling

Summary

Affiliation: Martin Luther University
Country: Germany

Publications

  1. ncbi Autoantibodies to the inhibitor of apoptosis protein survivin in patients with brain tumors
    Ariane Söling
    Molecular Neurooncology Laboratory, Department of Neurosurgery, Martin Luther University Halle Wittenberg, D 06097 Halle, Germany
    Int J Oncol 30:123-8. 2007
  2. pmc Dendritic cell therapy of primary brain tumors
    A Soling
    Department of Neurosurgery, Martin Luther University, Halle, Germany
    Mol Med 7:659-67. 2001
  3. ncbi Bioluminescence imaging in vivo - application to cancer research
    Ariane Söling
    Molecular Neurooncology Laboratory, ZAMED, Heinrich Damerow Strasse 1, 06097, Halle, Germany
    Expert Opin Biol Ther 3:1163-72. 2003
  4. ncbi Minichromosome maintenance protein 3 elicits a cancer-restricted immune response in patients with brain malignancies and is a strong independent predictor of survival in patients with anaplastic astrocytoma
    Ariane Söling
    Department of Neurosurgery, Martin Luther University Halle Wittenberg, Halle, Germany
    Clin Cancer Res 11:249-58. 2005
  5. ncbi Intracellular localization of Herpes simplex virus type 1 thymidine kinase fused to different fluorescent proteins depends on choice of fluorescent tag
    Ariane Söling
    Molecular Neurooncology Laboratory, Department of Neurosurgery, Martin Luther University Halle Wittenberg, Heinrich Damerow Strasse 1, 06097, Halle, Germany
    FEBS Lett 527:153-8. 2002

Detail Information

Publications5

  1. ncbi Autoantibodies to the inhibitor of apoptosis protein survivin in patients with brain tumors
    Ariane Söling
    Molecular Neurooncology Laboratory, Department of Neurosurgery, Martin Luther University Halle Wittenberg, D 06097 Halle, Germany
    Int J Oncol 30:123-8. 2007
    ..Anti-survivin antibodies may represent attractive tools for diagnosis and follow-up of brain tumors...
  2. pmc Dendritic cell therapy of primary brain tumors
    A Soling
    Department of Neurosurgery, Martin Luther University, Halle, Germany
    Mol Med 7:659-67. 2001
    ..DC therapy as an adjuvant treatment for patients with malignant glioma seems to be biologically safe. Further clinical studies are warranted...
  3. ncbi Bioluminescence imaging in vivo - application to cancer research
    Ariane Söling
    Molecular Neurooncology Laboratory, ZAMED, Heinrich Damerow Strasse 1, 06097, Halle, Germany
    Expert Opin Biol Ther 3:1163-72. 2003
    ..This review discusses the application of BLI to cancer research in general and to the area of experimental neuro-oncology in particular...
  4. ncbi Minichromosome maintenance protein 3 elicits a cancer-restricted immune response in patients with brain malignancies and is a strong independent predictor of survival in patients with anaplastic astrocytoma
    Ariane Söling
    Department of Neurosurgery, Martin Luther University Halle Wittenberg, Halle, Germany
    Clin Cancer Res 11:249-58. 2005
    ..Informative tumor markers may represent prognostic factors for response to therapy and outcome as well as potential targets for novel anticancer therapies...
  5. ncbi Intracellular localization of Herpes simplex virus type 1 thymidine kinase fused to different fluorescent proteins depends on choice of fluorescent tag
    Ariane Söling
    Molecular Neurooncology Laboratory, Department of Neurosurgery, Martin Luther University Halle Wittenberg, Heinrich Damerow Strasse 1, 06097, Halle, Germany
    FEBS Lett 527:153-8. 2002
    ..As enzyme localization may influence HSV-TK activity, this observation is of potential importance to gene therapy studies...